KEDPLASMA, LLC Information

KEDPlasma currently operates twelve plasma collection centers in the United States, four centers in Germany and three centers in Hungary, with all centers having approval by European authorities and/or the US Food and Drug Administration. The company's collection center in Buffalo, New York is specialized in collecting hyper-immune Anti-D human plasma for the manufacture of an Anti-D immunoglobulin pharmaceutical product for the prevention of hemolytic disease of the fetus and newborn (HDFN). State-of-the-art production facilities producing a wide range of products and an unwavering commitment to research and development are the key factors of Kedrion's success.